BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 22445908)

  • 21. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
    Topcul M; Cetin I
    J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
    Shan NL; Shin Y; Yang G; Furmanski P; Suh N
    Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
    Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma.
    Lu YB; Sun TJ; Chen YT; Cai ZY; Zhao JY; Miao F; Yang YN; Wang SX
    Technol Cancer Res Treat; 2020; 19():1533033820948053. PubMed ID: 33089751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.
    Li P; Yang R; Gao WQ
    Mol Cancer; 2014 Mar; 13():55. PubMed ID: 24618337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells.
    Barman S; Fatima I; Singh AB; Dhawan P
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonic stem cell factors and pancreatic cancer.
    Herreros-Villanueva M; Bujanda L; Billadeau DD; Zhang JS
    World J Gastroenterol; 2014 Mar; 20(9):2247-54. PubMed ID: 24605024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-to-mesenchymal-like transition events in melanoma.
    Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
    FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 37. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
    Dang H; Ding W; Emerson D; Rountree CB
    BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells: a potential target for cancer therapy.
    Qiu H; Fang X; Luo Q; Ouyang G
    Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.